pyrazinamide has been researched along with Cirrhosis, Liver in 8 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed." | 7.83 | Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016) |
| "A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed." | 3.83 | Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016) |
| "kg-1) and an increase in half-life from 9." | 1.28 | Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency. ( Duwoos, H; Lacroix, C; Lafont, O; Phan Hoang, T; Tranvouez, JL, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, N | 1 |
| Kedarisetty, CK | 1 |
| Kumar, S | 1 |
| Khillan, V | 1 |
| Sarin, SK | 1 |
| Attia, MS | 1 |
| Al-Radadi, NS | 1 |
| COTTIN, S | 1 |
| COZAN, R | 1 |
| VERAN, P | 1 |
| Panchabhai, TS | 1 |
| Ambarkhane, SV | 1 |
| Joshi, AS | 1 |
| Samant, BD | 1 |
| Rege, NN | 1 |
| Gómez Mont, F | 1 |
| Landa, L | 1 |
| Ramírez, C | 1 |
| Perches, A | 1 |
| Lacroix, C | 1 |
| Tranvouez, JL | 1 |
| Phan Hoang, T | 1 |
| Duwoos, H | 1 |
| Lafont, O | 1 |
| Rabina, EV | 1 |
| Semichastnova, AG | 1 |
| Golubiatnikova, GA | 1 |
| Michelis, MF | 1 |
| Warms, PC | 1 |
| Fusco, RD | 1 |
| Davis, BB | 1 |
1 review available for pyrazinamide and Cirrhosis, Liver
| Article | Year |
|---|---|
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; L | 2014 |
7 other studies available for pyrazinamide and Cirrhosis, Liver
| Article | Year |
|---|---|
Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy.
Topics: Adult; Biomarkers; Early Diagnosis; Equipment Design; Equipment Failure Analysis; Female; Hepatic En | 2016 |
[APROPOS OF ETHIONAMIDE JAUNDICE].
Topics: Alanine Transaminase; Alcoholism; Aminosalicylic Acid; Aminosalicylic Acids; Aspartate Aminotransfer | 1964 |
Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study.
Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; I | 2008 |
[Management of ascites in the cirrhotic patient using a 6-chloro-pyrazinamine derivative. I. Metabolic studies].
Topics: Ascites; Diuresis; Ethacrynic Acid; Humans; Liver Cirrhosis; Pyrazinamide; Spironolactone | 1966 |
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Liver Cirrhosis; Liver Funct | 1990 |
[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
Topics: Aged; Agranulocytosis; Antitubercular Agents; Carcinoma, Hepatocellular; Chemical and Drug Induced L | 1972 |
Hypouricemia and hyperuricosuria in Laennec cirrhosis.
Topics: Alcoholism; Bilirubin; Creatinine; Fatty Liver; Humans; Kidney Function Tests; Kidney Tubules; Liver | 1974 |